During the highly regulated process of wound healing the expression of the interstitial collagens I and III is increased in a time-dependent fashion. Although ultrastructural and in vitro studies suggest a physiologic role of collagen VI in the organization of extracellular matrix deposition, nothing is known about its role in wound healing. Therefore, we studied collagen VI gene expression during wound healing in humans compared to that of collagens I and III. The presence of specific al (VI) and a3(VI) mRNA species in scar tissue was demonstrated by Northern blot analysis. Quantification of mRNA expression by dot blot analysis and in situ hybridization indicated that like for the interstitial collagens I and III collagen VI gene expression was increased during wound healing, reaching its maximum 2 weeks after initial insult. In W ound healing is a highly regulated event. The different phases include the infiltration by inflammatory cells, the formation of granulation tissue and the deposition of connective tissue, which finally leads to the restoration of the normal architecture [1] . Previous studies have investigated the expression of the interstitial collagens type I and III during wound healing both at the protein and at the gene level [2] [3] [4] [5] . Collagen gene expression appears to be regulated in a time-dependent fashion. In the early phase of wound healing the expression of a1 (I) and al(III) collagen chains is coordinately increased throughout the entire dermis. In later stages the gene expression is rapidly down regulated, first in the lower dermis, and later also in the papillary dermis as well. In contrast, little is known about the role of type VI collagen in the process of wound healing. :329-334, 1993 Type VI collagen is a ubiquitous component of extracellular matrices present in most connective tissues [6] [7] [8] . It is a heterotrimer composed of three polypeptide chains, a1(VI), a2(VI) and a3(VI), with molecular masses of approximately 140, 140, and 260 kDa, respectively [9, 10] . Whereas the al(VI) and a2(VI) collagen genes are both located on chromosome 21, the a3(VI) collagen gene is located on chromosome 2 [11] . Major mRNA species encoding these chains have a size of 4.2 kb (a1), 3.5 kb (a2), and 8.5 kb (a3) [11] . In vitro experiments have indicated that mRNA expression of the constituent chains is differentially regulated and that the synthesis of the a3(VI) chain appears to be the rate-limiting step for the productio~ of intact ~ollagen VI [12] . The monomer of type VI collagen IS charactenzed by a rather short triple helix (length 105 nm) flanked on each side by large globular domains resulting in a dumbell-shaped appearance. These monomers have the potential to form disulfide-linked dimers and tetramers that are thought to represent the building blocks of tissue microfibrils [6] .
During the highly regulated process of wound healing the expression of the interstitial collagens I and III is increased in a time-dependent fashion. Although ultrastructural and in vitro studies suggest a physiologic role of collagen VI in the organization of extracellular matrix deposition, nothing is known about its role in wound healing. Therefore, we studied collagen VI gene expression during wound healing in humans compared to that of collagens I and III. The presence of specific al (VI) and a3(VI) mRNA species in scar tissue was demonstrated by Northern blot analysis. Quantification of mRNA expression by dot blot analysis and in situ hybridization indicated that like for the interstitial collagens I and III collagen VI gene expression was increased during wound healing, reaching its maximum 2 weeks after initial insult. In W ound healing is a highly regulated event. The different phases include the infiltration by inflammatory cells, the formation of granulation tissue and the deposition of connective tissue, which finally leads to the restoration of the normal architecture [1] . Previous studies have investigated the expression of the interstitial collagens type I and III during wound healing both at the protein and at the gene level [2] [3] [4] [5] . Collagen gene expression appears to be regulated in a time-dependent fashion. In the early phase of wound healing the expression of a1 (I) and al(III) collagen chains is coordinately increased throughout the entire dermis. In later stages the gene expression is rapidly down regulated, first in the lower dermis, and later also in the papillary dermis as well. In contrast, little is known about the role of type VI collagen in the process of wound healing.
Manuscript received June 24, 1992 ; accepted for publication November 16, 1992. the late phase of wound healing like al(l) the al(VI) gene expression was not down regulated significantly. In contrast, a reduction of a3(VI) collagen gene expression was observed, as was for the al(III) collagen gene, indicating a non-coordinate regulation of these chains. Collagen VI gene expression could be localized to fibroblast-like cells and to endothelial cells of newly formed vessels. Collagen VI gene expression was undetectable in smooth muscle cells and myoepithelial cells of eccrine glands. These results indicate that collagen VI gene expression is regulated in a time-dependent fashion and that fibroblasts and endothelial cells appear to play an important role in collagen VI synthesis during wound healing.] Invest DermatoI100: [329] [330] [331] [332] [333] [334] 1993 Type VI collagen is a ubiquitous component of extracellular matrices present in most connective tissues [6] [7] [8] . It is a heterotrimer composed of three polypeptide chains, a1(VI), a2(VI) and a3(VI), with molecular masses of approximately 140, 140, and 260 kDa, respectively [9, 10] . Whereas the al(VI) and a2(VI) collagen genes are both located on chromosome 21, the a3(VI) collagen gene is located on chromosome 2 [11] . Major mRNA species encoding these chains have a size of 4.2 kb (a1), 3 .5 kb (a2), and 8.5 kb (a3) [11] . In vitro experiments have indicated that mRNA expression of the constituent chains is differentially regulated and that the synthesis of the a3(VI) chain appears to be the rate-limiting step for the productio~ of intact ~ollagen VI [12] . The monomer of type VI collagen IS charactenzed by a rather short triple helix (length 105 nm) flanked on each side by large globular domains resulting in a dumbell-shaped appearance. These monomers have the potential to form disulfide-linked dimers and tetramers that are thought to represent the building blocks of tissue microfibrils [6] .
The biologic functions of type VI collagen are not yet fully understood. Type VI collagen networks have been identified in the vicinity of interstitial collagen and basement membranes of nerves and blood vessels by immunoelectronmicroscopy suggesting that these type VI collagen micro fibrils may function as a mechanical link between these structures and the surrounding connective tissues [13] .
III vitro experiments have shown that pepsin-solubilized and intact type VI collagen substrates mediate attachment and spreading of several cell types including fibroblasts [14] . Cell-attachment mediating properties have also been ascribed to a fusion protein containing the collagenous domain of the a3(VI) chain [15] .
Furthermore, recent studies have shown that the globular domains of type VI collagen contain motifs similar to type A domains of von Willebrand factor, which have been shown to bind to extra-0022-202X/93/$06.00 Copyright © 1993 by The Society for Investigative Dermatology, Inc. cellular matrix such as type I collagen, implying a possible bridging role of type VI coll agen with other matrix proteins in connective tissues [15 -17] .
All of these findin gs suggest that type VI collagen may play an important role in the organization of a coordinate matrix deposition as is required for wound healing of primary intent. Therefore, the present study was designed to characterize the expression of collage n VI mRN A species in comparison to that of the interstitial collagens type I and III in wound healing.
MATERIALS AND METHODS
Preparation of Tissue Samples The study was performed on re-excision biopsy specimens obtained from patients 8, 11, 17, 21, 24 , and 34 d after initial wounding for removal of a malignant melanoma. All wounds were healing by primary intention. Normal control skin was obtained from healthy volunteers. All these fullthickness biopsies were obtained under local anesthesia after informed consent. These tissue specimens were immediately snap fro ze n in liquid nitrogen and stored at -80°C until used.
RNA Extraction and Analysis by Northern and Dot-Blot Hybridization Frozen biopsies were cut on dry ice into tiny sections and homogenized in 4 M guanidine-isothiocyanate containing 0.1 M 2-mercaptoethanol. After centrifugation at 14,000 rpm at 4°C for 15 min, supernatants were extracted with phenol (Serva, Heidelberg, Germany) and chloroform (J .T. Baker Chemicals B.V., Deventer, the N etherlands). RNA was then separated by ultracentrifugation through a 5.7 M cesium chloride cushion according to standard protocols [18] . For dot-blot ana lysis, serial dilutions of total RNA (2,1 , 0.5, and 0 ).Lg) were applied to nylon membranes (Gene Screen, DuPont, Boston) using a dot blot apparatus. For Northern blot analysis, total RNA [2) .Lg per lane for al(I), al(III), and al (VI) and 20).Lg per lane for a3(VI)] was separated by gel electrophoresis on 1 % agarose gels under denaturing conditions and transferred onto nylon membranes by capillary blotting. After crosslin king of RNA to the filters by exposure to UV light they were pre-hybridized in 50% formamide, 0.1 % sodium dodecylsulfate (SDS) , 5 X sodium chloride, sodium citrate buffer (SSC), 5 X Denhardt's solution, and sonicated herring sperm DNA (100).Lg/ ml). Hybridization was carried out with eDNA probes that had been labe led with 32P_dATP by random priming to specific activities of 2-5 X 10 8 cpm/).Lg (Amersham, UK) for 12 h at 42°C in the buffer described above. After hybridization filters were washed twice in 2 X SSC, 0.1 % SDS at room temperature for 10 min, followed by stringe nt washing in 0.1 X sse, 0.1 % SDS at 42° Cor 65 ° C for 15 min. Filters were then exposed to radiosensitive film (Kodak, xOmat AR) at -80°C. Relative amounts of RNA were measured by densitometry (Hirschmann Elscript 400) . Before rehybridization, filters were stripped in 0.1 X SSC, 0.1 X SDS at 90°C for 20 min.
Inserts isolated from the plasmids Hf-677 with a 1.4-kb insert specific for the al(I) collagen chain [19] , pIlI-33 with a 0.9-kb insert for the al(I1I) collagen chain [20] , P18 with a 1.8-kb insert for the al(VI) collagen chain, P24 with a 1.8-kb insert for a3(VI) collagen [21] , and D~-1 with a 264-bp inse rt for ~-tubulin [22] were used as hybridization probes.
Preparation of cRNA Probes To generate cRNA probes for the detection of al and a3 type VI collagen chain mRN A species by in situ hybridization, fragments of the original cDNA clones P18 [for al (VI)] and P24 [for a3(VI)] [21] were subcloned into Gem 3 vector (Promega Biotec, Madison, USA) containing SP6 and T7 RNA polymerase promoters on either side of the multiple cloning site. In brief, a 1.8-kb (1795-bp) fragment of the original cDNA clone P18 was excised by EcoRI, purified, and subsequently digested with Kpnl. A resulting 461-bp fragment from the 5' end of the ori ginal eDNA corresponding to the sequence coding for a major portion of the al(VI) triple-helical domain was subcloned into Gem 3 vector that had been prepared by linearization with Kpnl foll owed by digestion with EcoR!. Similarly, a 1.8-kb (1787-bp) EcoRI frag ment of the original cDNA clone P24 was purified and submitted to digestion with Sma!. A resulting 726-bp fragment Figure 1 . Schematic representation of cDNA fragments encoding for human al(VI) and a3(VI) collagen mRNA. The triple-helical domains are depicted as ope/J boxes. The original cDNA clones P18 and P24 [21] were cleaved with appropriate restriction enzymes. The resulting fragments P18 sub (461 bp) and P24 sub (726 bp) encode a major portion of the al(Vl) triple-helical domain and a large portion of the C-terminal globular domain of the a3(Vl) chain, respectively. These cDNA fragments were subcloned into Gem 3 vector and used as templates for the generation of cRNA probes for ill situ hybridization.
from the 3' end of the original eDNA clone P24, complementary to the sequence coding for a large portion of the C-terminal globular domain of the a3(VI) chain, was subcloned into the Smal/EcoRi site of Gem 3 vector (Fig 1) .
The hybridization specificity of the probes thus generated using these subcloned cDNA fragments as templates to al(Vl) and a3(VI) collagen mRN A species was verified by Northern blot analysis (data not shown) . cRNA probes for detection of mRNA foral(I) and al(I1I) collagen chain were described previously [3] . Following linearization with appropriate restriction enzymes, in vitro transcription was carried out for 90 min at 37 ° C in the presence of 1 ).Lg DNA template, 10 mM dithiothreitol (OTT) (Sigma, St. Louis, MO), 20 U RNasin (Promega Biotec), 500 ).Lmol each ATP, GTP, CTP (Boehringer, Mannheim, FRG), 10 ).Lmol of unlabeled UTP, 50 ).LCi of 35S_UTP (specific activity 1282 Ci/mmol; Amersham, UK), and 1).L1 (15-20 units) of SP6 or T7 polymerase (Promega Biotec). After digestion of the DNA templates with 2U of DNase I (Promega Biotec), RNA probes were extracted with phenol and chloroform, precipitated from 0.3 M sodium acetate with ethanol, and redissolved in 20 ).LI of water.
In Situ Hybridization The protocol for ;n s;tII hybridization has been described elsewhere [3J . Briefly, 5-).Lm frozen sections mounted on slides were hybridized with al(Vl), a3(Vl), al(IIl), and al (I) anti-sense riboprobes. After hybridization, the slides were washed and treated with RNase to remove non-specific binding, washed again, and dried . Subsequently, slides were dipped into NTB2 emulsion (Kodak) and exposed for 1 to 2 weeks at 4 ° C. Slides were developed in 019 (Kodak) and sections were stained with hematoxylin. To check the integrity of tissue RNA and the specificity of the hybridization, a cRN A probe for human suprabasal keratin [23] was used as positive control, and sense cRNA probes for al(Vl), a3(Vl) collagen were used as negative controls.
Combined Use of In Situ Hybridization and Immunohistochemistry For use of in situ hybridization and immunostaining on the same section, the slides were treated after in situ hybridization as follows: after RNase treatment, the slides were washed in PBS and dried for 30 min at room temperature. The slides were then incubated for 1.5 h at room temperature with mouse antibodies diluted in Dulbecco's modified (DMEM) supplemented with 10% fetal bovine serum (FBS) against vimentin (1: 10) [24, 25) ) , and a -smooth muscle actin (1 : 50) (kindly provided by Prof. G. Gabbiani) [27] . Slides were then incubated with peroxi- Control experiments were performed using PBS instead of primary antibodies. The color reaction was produced using 3-amino-9-ethylcarbazole in a final concentration of 0.008% in PBS for 40 min. The slides were dipped two times into distilled water, air dried, and submitted to autoradiography as described above.
Quantitative Evaluation of rnRNA Expression by In Situ Hybridization To chronologically compare the relative proportions of fibroblasts displaying positive hybridization signals, six biopsies (obtained on days 8, 11, 17, 21, and 24 after initial operations, and normal control skin) were cut and mounted on the same slides. These slides were hybridized with 0'1 (1),0'1 (III), 0'1 (VI), and a3(VI) collagen cRNA probes respectively and exposed in parallel under identical conditions (1.5 X 10 6 cpm riboprobe/section for 1 week). Five fields in each of the samples were randomly selected and all of the fibroblasts in each field were examined for the presence or absence of positive hybridization signals. Only fibroblasts with signals that were clearly above background were considered positive.
RESULTS
To identify the presence of specific mRNA species for the 0'1(1), 0'1 (III), 0'1 (VI), and 0'3 (VI) collagen chains in scar tissue, Northern blot analysis was performed. Total RNA was isolated from wound biopsy specimens and from normal control skin, and separated by agarose gel electrophoresis as described, confirming that the RNA was intact. Subsequent hybridization with the corresponding labeled cDNA probes revealed the presence of characteristic mRNA species for 0'1(1), 0'1 (III), a1(VI), as well as a3(VI) collagen chains (Fig 2) .
In an attempt to quantify the chronologic development of mRNA expression for collagen VI in comparison to that of collagens I and III during wound healing, dot blot analysis was performed of total RNA isolated from normal control skin and specimens obtained 8, 11, 14, and 34 d after initial insult (Fig 3) . The expression of all mRNA species tested [0'1(1), a3(III), a1(VI) and a3(VI)] was increased during wound healing, reaching its maximum 2 weeks after the initial insult. Iriatl- gles) mRNA species were determined by dot blot analysis as described. Total RNA was isolated from scar tissues on days S, 11, 14, and 34 after initial operation. To eliminate differences due to unequal amounts of total RNA, the filters were stripped and rehybridized with a cDNA probe specific for ft-tubulin. The densitometry values of each collagen mRNA species were corrected for the levels of ft-tubuIin mRNA and expressed as arbitrary densitometry units. The expression of all four mRNA species evaluated increased until reaching its maximum on days 11 to 14. Thereafter, a decline of mRNA expression could only be observed for the 0'1 (III) and O'3(VI) chains.
(111) (closed squares), O'I(VI) (opw triatlgles) , 0'3(VI) (closed
cline. In contrast, mRNA expression for the 0'1 (I) and 0'1 (VI) collagen chains was still upregulated on day 34 after insult. . Attempts to quantif~ specific mRNAs by dot blot analysis of total tissue RNA. have the disadvantage of not allowing an estimation of the proportIOns of normal S~1n to actual wounded skin in the specimen, thus not allOWing a fair representation of changes in mRNA levels at the actual site of the lesion. Therefore, we also tried to ~uantify loc~lized col. lagen mRNA expression by i" situ hybridizatIOn as ~es~n.bed. ThiS al.lowed to assess mRNA expression at the I~vel of indiVidual cells, directly at the site of the lesion. The expression of mRNAs for type VI collagen and the interstitial collagens I and III was clearly dependent on the phase of wound healing (Fig 4) . The number of cells expressing 0'1 (VI) and 0'3(VI) mRNA inreased in. the early phase and reached a plateau 11 d after initial Insult. TIllS was paralleled by a similar increase in collagen I and III mRNA expression. In the later phase there was clear evidence for a discoordinat.e regulation of 0'1 (VI) and a3(VI) mRNA expression. The expression of a3(VI) mRNA started to decline after day 17. In contras~, no reduction from the plateau level of 0'1 (VI) mRNA expressIOn could be observed until day 24. In comparison, the number of cells displaying a positive signal for al(III) mRNA also started to decline after day 17, whereas that with a positive 0'1(1) mRNA signal remained at almost maximal levels throughout day 24 (Fig 4) .
Itl situ hybridization also allowed determination of the localization of cells expressing collagen VI mRNA during the different phases of wound healing (data not shown) . Until day 17, a simi lar distribution of cells yielding positive signals for a1(VI) and a3(VI), as well as 0'1(1) and 0'1 (III), mRNA was observed throughout the entire dermis at the incision site. Later on day 24, when 0'1 (III) and a3(VI) mRNA were down regulated again, fibroblast-like cells expressing 0'1 (1),0'1 (III), and 0'1 (VI) mRNA were concentrated more in the papillary dermis. The number of cells displaying a positive 100 r------------------~ ..: signal for a3{VI) mRNA was lower than that expressing the other three mRNA species. At this stage a3{VI) mRNA expressing cells were mainly seen in the viciniry of newly formed blood vessels. It has been hypothesized that collagen-producing cells in the early phase of wound healing have characteristics of myofibroblasts (positive immunostaining for a-smooth muscle actin), a feature lost in the late stages of wound healing [28] . Therefore, we determined the phenorype of the cells expressing rype VI collagen, by combined application of immunostaining and in situ hybridization on the same section. Our findin gs are summarized in Table I and representative examples shown in Fig 5. Myoepithelial cells around eccrine glands stained positively with antibodies directed against a-smooth muscle actin. However, they did not express detectable levels of mRNA for collagen VI chains (Fig Sa) . Smooth muscle cells in the dermis were positive for desmin, but did not show positive mRNA signals for the a1(VI) or the a3{VI) collagen chain either (Fig 5b) . Positive a1{VI) and a3{VI) mRNA signals could only be detected in cells staining with antibodies directed against vimentin (Fig 5c) , identifying these cells as normal fibroblasts. However· , vimentin positive fibroblasts displaying P?sitive mRNA signals for the al{VI) and the a3{VI) collagen chams were also found in close promixiry of smooth muscle cells and nearby eccrine glands. Because endothelial cells have been reported to produce rype VI collagen [29] ' we also performed immunostaining with an antibody against von Willebrand factor. Indeed, positive mRNA signals for collagen VI could be detected in endothelial cells of newly formed vessels in the healing wound (Fig 5d) .
DISCUSSION
In this study we were able to demonstrate that rype VI collagen gene expression is increased in the early phase of wound healing in humans and that the expression of mRNA for different constituent chains appears to be regulated discoordinately. Type VI collagen mRNA species are expressed by fibroblast-like mesenchymal cells, but not myofibroblasts. In addition, endothelial cells of newly formed vessels express mRNA for rype VI collagen.
Our data show that mRNA species for the collagen VI chains are abundant~y ~xpressed in the early phase of wound healing in a ~anner snmlar to that of the interstitial collagens I and III. The mcreased gene expression of the latter two collagens in the early ph.ase of wound heal. ing .observed here confirms previous reports on pnmary :vound .he~lm~ m humans and rats [2 -5 J. The time-dependent regIOnal dlstnbutlon of a1(I) and a1{III) mRNA expressing cells could also be confirmed. Both the time-dependent, increased rype VI collagen gene expression as well as the regional distribution of mRNA expressing cells appeared to be analogous to that of the interstitial collagens.
We could demonstrate that collagen VI mRNA is mainly expressed by fibroblastic cells. However, endothelial cells of newly formed vessels also yielded positive rype VI mRNA signals. These data are in agreement with studies describing increased collagen VI g~ne expression in keloid [30] and neurofibroma [29] , as well as With the fact that collagen VI was first isolated from the vessel wall [31] . They also corroborate in vitro findings that fibroblasts and endothelial cells in monolayer culture produce collagen VI [32, 33] . Collagen VI synthesis has also been demonstrated in cultured smooth muscle cells isolated from chick embryo and adult human vessels [3.4,35] . However, no collagen VI mRNA signal could be detected m smooth muscle cells of the dermis, neither within nor arou.n? ~he wound. This discrepancy could be explained by the low sensltlVlry of the assay or by the fact that cells may rapidly alter their phenory~e. under culture conditions [36 -38] .
In addition to collagen VI gene expressing endothelial cells of newly formed vessels, fibroblast-like cells expressing collagen VI mRNA were observed in immediate viciniry of these blood vessels. This observation implies the possibiliry that both endothelial cells as well as surro.unding fibroblasts contribute to the deposition of collagen VI, wluch has been observed by immunoelectronmicroscopy near the basement membrane of vessel walls [13] .
The finding that a3(VI) mRNA is down regulated during the later phase of wound healin~ whereas a1{VI) is still up regulated may be a reflection of the different chromosomal location of the genes for the .a1{VI) chain and the a3{VI) chain [11] . It is also in ~ccord~n~e Wit? previous in vitro studies from our laboratory revealmg a snn.Iiar dlscoordinate regulation of the different collagen VI a-chams m response to IF~-y treatment of cells [12] . In that particular study,. th.e.gene expressIOn for the a3(VI) chain appeared to be the rate-lnmtmg step for the overall collagen VI synthesis. In analogy, it may be ~ostulated that the observed down regulation of the a3{VI) mRNA m the later stage of wound healing may be sufficient for a down r~gulation of total collagen VI protein synthesis.
Recently, It has been reported that the a3(VI) chain binds to collagen I [15] and that collagen VI has important cell-attachment prop~rtie.s [14] ,.i,:dicating a potential bridging function of collagen VI With l11terstltlal collagen fibers during the organization of con- 100,um.) nective tissues [15] . Observations that collagen VI gene expression is increased in active fibrotic syndromes such as the eosinophilia myalgia syndrome [39] or systemic sclerosis [40] , in addition to our observations of increased expression of collagen VI in the early phase of wound healing with subsequent down regulation during the later phase, provide further support for the hypothesis that this molecule may playa key role in matrix organization that merits further investigation .
Dr. 00110 
